drugset / Trial / NCT01720290
Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Asia. The aim of this trial is to compare repaglinide and metformin administered alone or in combination in subjects with type 2 diabetes.
Timeline
- Start
- 2002-07-25
- Primary completion
- 2003-02-25
- Completion
- 2003-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 1000 mg | — |
| Subject | Repaglinide | Small molecule | — | — |